On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


After Growth in CBD Sector, ChineseInvestors.com Inc. (CIIX) Resumes Financial Consultancy Services for Chinese Community in the US

  • CIIX CEO forecast that the company’s sales will reach $11­­­-12 million by 2020 during an interview with Redchip Money Report
  • CIIX recently opened a hemp-based CBD product retail store in the Chinese-concentrated area of San Gabriel, California
  • The company is geared up to concentrate on financial consultancy and related services targeted at the Chinese community in the United States

Warren Wang, CEO of ChineseInvestors.com Inc. (OTCQB: CIIX), predicted during a recent interview with Redchip Money Report that the company’s sales will reach $11‑12 million by 2020 (http://ibn.fm/KDzDV). Wang further emphasized that though CBD had played an important role in the growth of the company, CIIX offers diverse services that aid in its growth, development and stability.

CIIX offers its Chinese-speaking audience daily investment information through its online information portal, TV and radio shows, podcasts and real-time market commentary. CIIX also conducts online/offline cryptocurrency and blockchain education classes.

ChineseInvestors.com was founded in 1999 and has been primarily engaged in providing financial information and services to the Chinese-speaking investor community in the United States. With its immense knowledge and expertise in the financial realm, CIIX is leveraging the stupendous growth of the CBD products industry, which is expected to reach $20 billion in sales by 2024 (http://ibn.fm/zXA8l). In 2019, the company experienced an increase of 81 percent in revenue, which Wang attributes to CIIX’s hemp sales (http://ibn.fm/Lc4NI). CIIX is a leading Chinese CBD company, catering to four million Chinese-speaking Americans and Canadians.

During the interview, Wang also stated that, with the high spending capacity of Chinese consumers and huge market opportunities in the United States, Asia, and China specifically, CIIX’s sales are expected to double in the next 12 months. More mergers and acquisitions are lined up for the company in both the Chinese and wider Asian markets.

CIIX launched a CBD product-based website, ChineseCBDoil.com, in January 2017, offering industrial hemp-derived products to Chinese-speaking people worldwide. Company headquarters are located in the Chinese-concentrated area of San Gabriel, California, where CIIX opened its first mall popup kiosk on May 1, 2019 (http://ibn.fm/Haqhi). This retail outlet also offers customers hemp-derived and other CBD products.

In addition to its reach into the hemp space, the company’s main focus and core revenue source remains developing and marketing web-based tools designed to provide financial information and investment knowledge to the Chinese-speaking community in America. The company’s original website, ChineseFN.com (http://ibn.fm/CbdZS), has a following of more than 100,000 registered users and 5,000 subscribers.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

From Our Blog

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Helomics Leverages Cutting-Edge Tech and Datasets to Improve Cancer Outcomes

May 22, 2020

POAI subsidiary Helomics helps oncologists individualize cancer treatment using patient-derived tumor models to improve outcomes Helomics’ tumor genomic and drug response database is one of the largest in the world with over 150,000 tumors across 137 cancer types Expected CAGR of 10.3% from 2018-2024 for oncology segment of precision medicine industry The relationship between a […]

Rotate your device 90° to view site.